What we review
Formula composition, intended users and application, exposure, raw material information, available product tests and warnings are reviewed together. An ingredient list alone cannot establish the safety of a finished product.
What you receive
The agreed assessment report and identified data gaps, with the reasoning, warnings and conditions relevant to the assessed product. A positive safety conclusion depends on adequate evidence; it cannot be promised before assessment.
What to prepare
Product names and variants; a quantitative formula; raw material specifications and supplier safety information; intended use; packaging details; available stability and microbiological evidence; and proposed labels. We confirm any additional requirements for your product.
Scope, timing and quotation
Tell us how many formulas and variants are involved, the intended markets and what documentation is available. We confirm the scope, fee and expected timing after reviewing the brief. Missing evidence, testing or formula changes can affect the schedule.
After assessment
Keep the assessment connected to the actual product. Changes to ingredients, concentrations, use, packaging or safety information should be brought back for review. PIF organisation, label review and notifications can be scoped alongside the assessment.